Slingshot members are tracking this corporate initiative:
Aimmune (AIMT) Announces $145MM Investment From Nestle Health Science (NSRGY) as Part of Two-Year Collaboration Agreement to Develop Food Allergy Therapies
Slingshot Insights Explained
Strategic Initiative Date
Announcement Date: Nov 04, 2016 Projected Implementation: Q4, 2016 Relevance Tracked Until: Q4, 2018
Don’t see a project related to the strategic initiative you care about?
Related Keywords Investment, Two-year Collaboration Agreement, Food Allergy Therapies